Antisera and other blood fractions in   China

Exports In 2022, China exported $122M in Antisera and other blood fractions, making it the 12th largest exporter of Antisera and other blood fractions in the world. At the same year, Antisera and other blood fractions was the 2206th most exported product in China. The main destination of Antisera and other blood fractions exports from China are: Argentina ($30.4M), United States ($14.2M), Ecuador ($8.24M), Germany ($4.97M), and Chinese Taipei ($4.56M).

The fastest growing export markets for Antisera and other blood fractions of China between 2021 and 2022 were Argentina ($13.4M), Uganda ($2.37M), and Sierra Leone ($696k).

Imports In 2022, China imported $724M in Antisera and other blood fractions, becoming the 2nd largest importer of Antisera and other blood fractions in the world. At the same year, Antisera and other blood fractions was the 325th most imported product in China. China imports Antisera and other blood fractions primarily from: Ireland ($446M), South Korea ($72.2M), United States ($66.2M), Denmark ($57.3M), and France ($31.1M).

The fastest growing import markets in Antisera and other blood fractions for China between 2021 and 2022 were Denmark ($50.2M), South Korea ($30.3M), and Russia ($1.05M).

COMPANIES In 2023, leading companies such as IKEA SUPPLY AG (3.6M), WAL-MART INC. (2.68M), and AMAZON SERVICES LLC (1.42M) were at the forefront of shipping Antisera and other blood fractions from China to the United States.